Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · IEX Real-Time Price · USD
19.55
+0.16 (0.80%)
Jul 22, 2024, 10:07 AM EDT - Market open
Tyra Biosciences Employees
Tyra Biosciences had 49 employees as of December 31, 2023. The number of employees increased by 11 or 28.95% compared to the previous year.
Employees
49
Change (1Y)
11
Growth (1Y)
28.95%
Revenue / Employee
n/a
Profits / Employee
-$1,539,714
Market Cap
1.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 49 | 11 | 28.95% |
| Dec 31, 2022 | 38 | 13 | 52.00% |
| Dec 31, 2021 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| OPKO Health | 3,930 |
| Avanos Medical | 3,771 |
| Tarsus Pharmaceuticals | 244 |
| Calliditas Therapeutics AB (publ) | 217 |
| Collegium Pharmaceutical | 197 |
| Tango Therapeutics | 140 |
| Cullinan Oncology | 85 |
| Enliven Therapeutics | 46 |
TYRA News
- 19 days ago - Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH) - PRNewsWire
- 2 months ago - Tyra Biosciences to Present at Upcoming Investor Conferences - PRNewsWire
- 2 months ago - Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights - PRNewsWire
- 2 months ago - Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. - PRNewsWire
- 4 months ago - Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights - PRNewsWire
- 5 months ago - Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference - PRNewsWire
- 6 months ago - Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing - PRNewsWire
- 6 months ago - Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia - PRNewsWire